Expert Opinion on Pharmacotherapy, Volume 24, Issue 4 (2023)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Pharmacotherapy, Volume 24, Issue 4 (2023)

See all volumes and issues
Vol 25, 2024 Volume 24, 2023 Vol 23, 2022 Vol 22, 2021 Vol 21, 2020 Vol 20, 2019 Vol 19, 2018 Vol 18, 2017 Vol 17, 2016 Vol 16, 2015 Vol 15, 2014 Vol 14, 2013 Vol 13, 2012 Vol 12, 2011 Vol 11, 2010 Vol 10, 2009 Vol 9, 2008 Vol 8, 2007 Vol 7, 2006 Vol 6, 2005 Vol 5, 2004 Vol 4, 2003 Vol 3, 2002 Vol 2, 2001 Vol 1, 1999-2000
Download citations Download PDFs Download issue

Editorial

Editorial
How does a clinician approach the pharmacological management of opioid use disorders in pregnant women and pregnant people?
Hendrée E. Jones
Pages: 401-405
Published online: 12 Jan 2023
First Page PreviewforHow does a clinician approach the pharmacological management of opioid use disorders in pregnant women and pregnant people? | Full Text | References | PDF (246.9 KB) | EPUB
  • 1230 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Drug Evaluation

Article
Profile of tirzepatide in the management of type 2 diabetes mellitus: design, development, and place in therapy
Lina Naseralallah & Bodoor Aboujabal
Pages: 407-418
Published online: 26 Feb 2023
AbstractforProfile of tirzepatide in the management of type 2 diabetes mellitus: design, development, and place in therapy | Full Text | References | PDF (419.5 KB) | EPUB | Supplemental
  • 4079 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Special Report

Article
The pharmacological management of gambling disorder: if, when, and how
Mauro Pettorruso, Francesco Di Carlo, Vincenzo Maria Romeo, Susana Jimenez-Murcia, Jon E Grant, Giovanni Martinotti & Massimo Di Giannantonio
Pages: 419-423
Published online: 02 Feb 2023
AbstractforThe pharmacological management of gambling disorder: if, when, and how | Full Text | References | PDF (264.4 KB) | EPUB
  • 189 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review
Evidence-based prescribing of medications for ADHD: where are we in 2023?
Samuele Cortese
Pages: 425-434
Published online: 21 Jan 2023
AbstractforEvidence-based prescribing of medications for ADHD: where are we in 2023? | Full Text | References | PDF (351.4 KB) | EPUB
  • 9449 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Current advances in the pharmacological prevention and management of cognitive dysfunction in multiple sclerosis
Angelo Bellinvia, Emilio Portaccio & Maria Pia Amato
Pages: 435-451
Published online: 01 Jan 2023
AbstractforCurrent advances in the pharmacological prevention and management of cognitive dysfunction in multiple sclerosis | Full Text | References | PDF (425.9 KB) | EPUB
  • 220 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
Advances in the available pharmacotherapy for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Antonio Greco, Simone Finocchiaro, Dominick J. Angiolillo & Davide Capodanno
Pages: 453-471
Published online: 07 Feb 2023
AbstractforAdvances in the available pharmacotherapy for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation | Full Text | References | PDF (3.5 MB) | EPUB
  • 312 Views
  • 2 CrossRef citations
  • 0Altmetric
Review
Long-acting antipsychotics in the treatment of schizophrenia: opportunities and challenges
Peter M. Haddad & Christoph U. Correll
Pages: 473-493
Published online: 15 Mar 2023
AbstractforLong-acting antipsychotics in the treatment of schizophrenia: opportunities and challenges | Full Text | References | PDF (5.1 MB) | EPUB
  • 537 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
An update on the use of sphingosine 1-phosphate receptor modulators for the treatment of relapsing multiple sclerosis
Laura Dumitrescu, Athanasios Papathanasiou, Catalina Coclitu, Afagh Garjani, Nikos Evangelou, Cris S. Constantinescu, Bogdan Ovidiu Popescu & Radu Tanasescu
Pages: 495-509
Published online: 22 Mar 2023
AbstractforAn update on the use of sphingosine 1-phosphate receptor modulators for the treatment of relapsing multiple sclerosis | Full Text | References | PDF (412.4 KB) | EPUB
  • 2996 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Meta-Analysis

The correlations between steady-state concentration, duration of action and molecular weight of GLP-1RAs and their efficacy and gastrointestinal side effects in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
Ruoyang Jiao, Chu Lin, Shuzhen Bai, Xiaoling Cai, Suiyuan Hu, Fang Lv, Wenjia Yang, Xingyun Zhu & Linong Ji
Pages: 511-521
Published online: 22 Feb 2023
AbstractforThe correlations between steady-state concentration, duration of action and molecular weight of GLP-1RAs and their efficacy and gastrointestinal side effects in patients with type 2 diabetes mellitus: a systematic review and meta-analysis | Full Text | References | PDF (3.2 MB) | EPUB | Supplemental
  • 223 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Research

Article
Risk management of medication errors: a novel conceptual framework
Richard Despott, Janet Sultana, Liberato Camilleri, Janis Vella Szij & Anthony Serracino Inglott
Pages: 523-534
Published online: 22 Feb 2023
AbstractforRisk management of medication errors: a novel conceptual framework | Full Text | References | PDF (773.5 KB) | EPUB
  • 242 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Effectiveness, persistence of use, and safety of orlistat and liraglutide in a group of patients with obesity
Luis Fernando Valladales-Restrepo, Nicolás Sánchez-Ramírez, Andrés Felipe Usma-Valencia, Andrés Gaviria-Mendoza, Manuel Enrique Machado-Duque & Jorge Enrique Machado-Alba
Pages: 535-543
Published online: 15 Feb 2023
AbstractforEffectiveness, persistence of use, and safety of orlistat and liraglutide in a group of patients with obesity | Full Text | References | PDF (450.4 KB) | EPUB
  • 287 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles